The timing of cyclophosphamide therapy in tumor-bearing rats affects the resistance to tumor challenge in survivors.

Cyclophosphamide given to rats 2 or 5 days after an injection of Yoshida ascites sarcoma cured approximately the same proportion of animals, but the resistance to a subsequent tumor challenge was found only in rats treated with the drug 5 days after tumor injection.